OZEM Holdings — Roundhill GLP-1 & Weight Loss ETF
Data updated: 2026-08-26
OZEM holds 26 securities. The top 10 make up 72.0% of net assets, led by Novo Nordisk A/S (12.96%) and Eli Lilly & (12.69%). Health Care (90.4%) and Funds & ETFs (9.6%) are the largest sectors, and 54.8% of the portfolio is in United States. No debt holdings are reported.
Holdings cover 110.14% of net asset value (97.63% of total assets; remainder is cash and receivables). As of June 30, 2026 · N-PORT.
OZEM Portfolio Holdings
26 holdings of Roundhill GLP-1 & Weight Loss ETF by percentage of net assets, from the fund's SEC N-PORT filing as of June 30, 2026.
| Holding | Ticker | Sector | % of net assets | Value (USD) |
|---|---|---|---|---|
| Novo Nordisk A/S | NVO | Health Care | 12.96% | $7.01M |
| Eli Lilly & Co | LLY | Health Care | 12.69% | $6.86M |
| Mount Vernon Liquid Assets Portfolio, LLC | — | Funds & ETFs | 9.93% | $5.37M |
| Pfizer Inc | PFE | Health Care | 6.38% | $3.45M |
| Kailera Therapeutics Inc | KLRA | Health Care | 6.21% | $3.36M |
| Viking Therapeutics Inc | VKTX | Health Care | 5.86% | $3.17M |
| CSPC Pharmaceutical Group Ltd | 1093 | Health Care | 5.32% | $2.88M |
| Chugai Pharmaceutical Co Ltd | 4519 | Health Care | 4.51% | $2.44M |
| Ascletis Pharma Inc | 1672 | Health Care | 4.20% | $2.27M |
| Zealand Pharma A/S | ZEAL | Health Care | 3.92% | $2.12M |
| Amgen Inc | AMGN | Health Care | 3.85% | $2.08M |
| AstraZeneca PLC | AZN | Health Care | 3.83% | $2.07M |
| Hanmi Pharm Co Ltd | 128940 | Health Care | 3.50% | $1.90M |
| Structure Therapeutics Inc | GPCR | Health Care | 3.05% | $1.65M |
| Roche Holding AG | ROP | Health Care | 3.03% | $1.64M |
| MBX Biosciences Inc | MBX | Health Care | 2.80% | $1.51M |
| United Laboratories International Holdings Ltd/The | 3933 | Health Care | 2.63% | $1.42M |
| Jiangsu Hengrui Pharmaceuticals Co Ltd | 1276 | Health Care | 2.58% | $1.40M |
| Hansoh Pharmaceutical Group Co Ltd | 3692 | Health Care | 2.54% | $1.37M |
| Innovent Biologics Inc | 1801 | Health Care | 2.37% | $1.28M |
| Gubra A/S | GUBRA | Health Care | 1.87% | $1.01M |
| Gilead Sciences Inc | GILD | Health Care | 1.73% | $938.07K |
| Rhythm Pharmaceuticals Inc | RYTM | Health Care | 1.64% | $884.46K |
| Shionogi & Co Ltd | 4507 | Health Care | 1.24% | $670.97K |
| WaVe Life Sciences Ltd | WVE | Health Care | 0.86% | $467.31K |
| First American Government Obligations Fund | FGXXX | Funds & ETFs | 0.62% | $335.01K |
OZEM Sector Allocation
Roundhill GLP-1 & Weight Loss ETF holdings grouped by sector, by share of the portfolio's market value.
| Sector | Weight | Holdings |
|---|---|---|
| Health Care | 90.4% | 24 |
| Funds & ETFs | 9.6% | 2 |
OZEM Country Allocation
Where Roundhill GLP-1 & Weight Loss ETF's holdings are domiciled, by percentage of net assets (largest 9).
| Country | % of net assets |
|---|---|
| United States | 54.8% |
| Denmark | 18.8% |
| China | 17.0% |
| Japan | 5.8% |
| United Kingdom | 3.8% |
| South Korea | 3.5% |
| Switzerland | 3.0% |
| Hong Kong SAR China | 2.6% |
| Singapore | 0.9% |
OZEM Portfolio Allocation
Asset-class allocation of Roundhill GLP-1 & Weight Loss ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.6% |
| Cash & Equivalents | 10.6% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.